Objective: To describe the experience in 22 patients with penile cancer.
INTRODUCTION
Penile cancer is an infrequent neoplasia, representing 0.5 to 5% of all male malignancies. The incidence is variable, in Europe it is approximately 0.5 to 1.6 in 100,000 individuals and 0.7-0.9 in 100,000 in the USA. In Mexico in the Histopathological Registry of Malignant Neoplasms in the year of 2003, 346 cases were reported with an incidence of 0.91 in 100,000 and 0.31 of all malignancies in that year, while mortality ocurred in 103 cases (Mortality rate of 0.2 in 100,000 males), representing the 0.17% of deads due to cancer (1, 2) .
It is more common in the sixth decade of life and the major risk factors are phimosis, poor hygiene and smoking. The presentation of penile cancer may vary greatly from forms of benign appearance to invasive carcinoma, which may prolong the time for the patient to seek medical care up to one year (1) .
Habitully it presents as a small lesion, with a papillary or flat growth pattern, which extends slowly and gradually. The most common site of metastasis are the inguinal lymph nodes.
The physical inguinal and genitalia exam is necessary for diagnosis, the confirmation of diagnosis is made by biopsy of suspicious lesions. The squamous cell carcinoma is the most frequent histological variant found in up to 95% of the cases. The staging system is the base for treatment, surgery is the most effective option for these patients. Due to the poor prognosis of penile cancer for life and function and its little incidence (3, 4) . The objective of this paper is to present the experience in the management at three years of penile cancer.
SUBJECTS AND METHODS
A cross-sectional study was conducted on patients with penile cancer attending a Second Level 
Statistical analyses
Descriptive statistics were used with measures of central tendency and dispersión, using the StatCalc for Mac program. All the patients were kept anonymous during the study. The overall survival at 5 years was 40.9% and the average survival time was 41.8 months.
RESULTS

There
( Table 4 , Figure 1 ).
DISCUSSION
Penile cancer is a rare disease (1). The incidence in men younger than 40 years old is 19% and 7% for men younger than 30 years old. Our patients showed a mean of 65 years, according with the world literature which describes that penile cancer occurs in men over 50 years old (2).
The average development time from onset of the injury until the diagnosis was 25 months. According with Lont AP et al who mentioned that the time of evolution since the appearance of lesions until the time of diagnosis is more than 12 months (5). Madsen BS et al described an intact foreskin in 25 -60 % of penile cancer patients (6) .
These findings differ with our study, because we found an intact foreskin in all our patients. The major medical background in the studied patients were; smoking and HPV infection. Fifteen patients (68.18%) presented some or the association of these two factors, the literature describes that smoking increases the risk of 3 to 4.5 times (5, 7 -9).
The clinical presentation varies, from a lesion with induration to an exophytic lesion, causing itching, burning in the foreskin and presence of an ulceration of the glans or the foreskin.
Pain is less frequent, however, in this study the most frequent reason for consultation was the presence of a penile lesion, asymptomatic in 27.3%, with pain in the penis, groin and loss weight in 9.1%. The 22.7% showed groin pain, the 27.3% presented pain in the groin and penis, the 9.1% with only penis pain and the 4.5% showed inguinal pain and loss weigth (9-11).
Burgers JK, et al mentioned that the presentation of the lesion is more frequent on the glans (48%), in the foreskin in 21% and on the glans and foreskin in 9%, in the coronal sulcus in 6% and in the body of the penis in less than 2% (9).
The patients delay medical treatment and refer injuries with more than one year of appearance before the diagnosis. In this study in 40.9% of the patients, the lesion was presented in the foreskin and glans, in 40.9% covered to the distal third of the penis; which is an unusual data in the literature, even though the time of evolution in these patients was similar to that reported in the literature (12 months) (1, 8, 10 -14) .
All of the smoking patients with HPV presented neurovascular invasion. In the reviewed literature we did not find any association between these factors and penile cancer (1, 15 -20) .
However, more prospectives and longitudinal studies are required to determine whether these factors are related or not. The patients with lesions larger than 5cm (83.3%, n=6) were smokers and some of them had association with HPV. Besides, 66.6% of the smokers had metastases at diagnosis and were also in advanced clinical stage. In the literature review we did not find any association with this factors (15 -21) . The squamous cell carcinoma is the most Experience in Penile Cancer 6 frequent (48-65%). In this study the 86.4% were squamous cell variety, other varieties were verrucous in 9.1% and sarcomatoid in 4.5%. It is mentioned that the sarcomatoid variety is very aggressive (1, 9, 11, 22 -24) . However, 4.5% (n=1) of patients with this variety were alive at the time of data collection.
All the patients with metastasis (n=6) were smokers and HPV positive, and all of the patients with a IV clinical stage (n=7) also had this background. The 75% (n=16) of patients with tissue invasion by histopathology were smokers and/or had HPV infection. The 85.71% (n=7) of the patients who died from lung metastases were also smokers. In the literature review we did not find any association between penile cancer and morbidity and mortality, but with the development of the disease (25 -30) .
Overall survival was 40.9% at 5 years and the average survival time was 41.818 months, which is similar to that reported in the world literatura (25, 30) . Due to the type of study, no measures of association between penile cancer and these factors were performed.
CONCLUSION
The penile cancer is a rare disease with high mortality with a late diagnosis. Measures to perform an early diagnosis are suggested and therefore improve prognosis, since treatment can be curative.
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